The Brazilian statutory exemption to pharmaceutical patents: beyond generics
by Carlos Alberto Rohrmann, Fabiola Moreira Gontijo
International Journal of Liability and Scientific Enquiry (IJLSE), Vol. 4, No. 1, 2011

Abstract: Brazilian patent law offers a statutory exception related specifically to pharmaceutical patents. That exception has a unique importance to the new aspects of the intellectual property rights and to the rights to public health. This article will present this statutory exception and analyse the consequences of its application. The text relates to the new international trends that regulate pharmaceutical patents, especially the relation between pharmaceutical patents and public health.

Online publication date: Sat, 29-Nov-2014

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Liability and Scientific Enquiry (IJLSE):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com